The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set
Open accessAbstract
Using quantitative radiomics, we demonstrate that computer-extracted magnetic resonance (MR) image-based tumor phenotypes can be predictive of the molecular classification of invasive breast cancers. Radiomics analysis was performed on 91 MRIs of biopsy-proven invasive breast cancers from National Cancer Institute’s multi-institutional TCGA/TCIA. Immunohistochemistry molecular classification was performed including estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, and for 84 cases, the molecular subtype (normal-like, luminal A, luminal B, HER2-enriched, and basal-like). Computerized quantitative image analysis included: three-dimensional lesion segmentation, phenotype extraction, and leave-one-case-out cross validation involving stepwise feature selection and linear discriminant analysis. The performance of the classifier model for molecular subtyping was evaluated using receiver operating characteristic analysis. The computer-extracted tumor phenotypes were able to distinguish between molecular prognostic indicators; area under the ROC curve values of 0.89, 0.69, 0.65, and 0.67 in the tasks of distinguishing between ER+ versus ER−, PR+ versus PR−, HER2+ versus HER2−, and triple-negative versus others, respectively. Statistically significant associations between tumor phenotypes and receptor status were observed. More aggressive cancers are likely to be larger in size with more heterogeneity in their contrast enhancement. Even after controlling for tumor size, a statistically significant trend was observed within each size group (P=0.04 for lesions ⩽2 cm; P=0.02 for lesions >2 to ⩽5 cm) as with the entire data set (P-value=0.006) for the relationship between enhancement texture (entropy) and molecular subtypes (normal-like, luminal A, luminal B, HER2-enriched, basal-like). In conclusion, computer-extracted image phenotypes show promise for high-throughput discrimination of breast cancer subtypes and may yield a quantitative predictive signature for advancing precision medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Textural Features for Image Classification
Haralick, R. M., Shanmugam, K., & Dinstein, I. (1973) · IEEE Transactions on Systems, Man, and Cybernetics · doi:10.1109/tsmc.1973.4309314 · Cited by 22,886
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Self-citationNishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499
Kendall, M. G. (1957) · Biometrika · doi:10.2307/2333282 · Cited by 6,383
Egner, J. R. (2010) · JAMA · doi:10.1001/jama.2010.1525 · Cited by 5,997
Cited by
Artificial intelligence in cancer imaging: Clinical challenges and applications
Bi, W. L., Hosny, A., Schabath, M. B., Giger, M. L., Birkbak, N. J., Mehrtash, A., Allison, T., Arnaout, O., Abbosh, C., Dunn, I. F., et al. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21552 · Cited by 1,846
Self-citationLimkin, E. J., Sun, R., Dercle, L., Zacharaki, E. I., Robert, C., Reuzé, S., Schernberg, A., Paragios, N., Deutsch, E., & Ferté, C. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx034 · Cited by 757
Deep learning in medical imaging and radiation therapy
Sahiner, B., Pezeshk, A., Hadjiiski, L. M., Wang, X., Drukker, K., Cha, K. H., Summers, R. M., & Giger, M. L. (2019) · Medical Physics · doi:10.1002/mp.13264 · Cited by 740
Self-citationAI in Medical Imaging Informatics: Current Challenges and Future Directions
Panayides, A. S., Amini, A., Filipovic, N. D., Sharma, A., Tsaftaris, S. A., Young, A., Foran, D., Do, N., Golemati, S., Kurc, T., et al. (2020) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2020.2991043 · Cited by 713
Braman, N. M., Etesami, M., Prasanna, P., Dubchuk, C., Gilmore, H., Tiwari, P., Plecha, D., & Madabhushi, A. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0846-1 · Cited by 632
Giger (2018) · doi:10.1016/j.jacr.2017.12.028 · Cited by 634
Beyond imaging: The promise of radiomics
Avanzo, M., Stancanello, J., & El Naqa, I. (2017) · Physica Medica · doi:10.1016/j.ejmp.2017.05.071 · Cited by 483
Multimodal data fusion for cancer biomarker discovery with deep learning
Steyaert, S., Pizurica, M., Nagaraj, D., Khandelwal, P., Hernandez-Boussard, T., Gentles, A. J., & Gevaert, O. (2023) · Nature Machine Intelligence · doi:10.1038/s42256-023-00633-5 · Cited by 402
Radiomics: from qualitative to quantitative imaging
Rogers, W., Thulasi Seetha, S., Refaee, T. A. G., Lieverse, R. I. Y., Granzier, R. W. Y., Ibrahim, A., Keek, S. A., Sanduleanu, S., Primakov, S. P., Beuque, M. P. L., et al. (2020) · The British Journal of Radiology · doi:10.1259/bjr.20190948 · Cited by 372
Braman, N., Prasanna, P., Whitney, J., Singh, S., Beig, N., Etesami, M., Bates, D. D. B., Gallagher, K., Bloch, B. N., Vulchi, M., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.2561 · Cited by 327
Saha, A., Harowicz, M. R., Grimm, L. J., Kim, C. E., Ghate, S. V., Walsh, R., & Mazurowski, M. A. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0185-8 · Cited by 310
Precision medicine and radiogenomics in breast cancer: new approaches toward diagnosis and treatment
Pinker, K., Chin, J., Melsaether, A. N., Morris, E. A., & Moy, L. (2018) · Radiology · doi:10.1148/radiol.2018172171 · Cited by 275
Self-citationRapid review: radiomics and breast cancer
Valdora, F., Houssami, N., Rossi, F., Calabrese, M., & Tagliafico, A. S. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4675-4 · Cited by 258
Tracking tumor biology with radiomics: a systematic review utilizing a radiomics quality score
Sanduleanu, S., Woodruff, H. C., de Jong, E. E. C., van Timmeren, J. E., Jochems, A., Dubois, L., & Lambin, P. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.03.033 · Cited by 242
Role of imaging in the era of precision medicine
Giardino, A., Gupta, S., Olson, E., Sepulveda, K., Lenchik, L., Ivanidze, J., Rakow-Penner, R., Patel, M. J., Subramaniam, R. M., & Ganeshan, D. (2017) · Academic Radiology · doi:10.1016/j.acra.2016.11.021 · Cited by 87
Radiogenomics for Precision Medicine With a Big Data Analytics Perspective
Panayides, A. S., Pattichis, M. S., Leandrou, S., Pitris, C., Constantinidou, A., & Pattichis, C. S. (2019) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2018.2879381 · Cited by 66
Radiology and multi-scale data integration for precision oncology
Paverd, H., Zormpas-Petridis, K., Clayton, H., Burge, S., & Crispin-Ortuzar, M. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00656-0 · Cited by 41
Simpson, G., Jin, W., Spieler, B., Portelance, L., Mellon, E., Kwon, D., Ford, J. C., & Dogan, N. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.807725 · Cited by 11
Metadata
- Authors
- Li, H., Zhu, Y., Burnside, E. S., Huang, E., Drukker, K., Hoadley, K. A., Fan, C., Conzen, S. D., Zuley, M., Net, J. M., Sutton, E., Whitman, G. J., Morris, E., Perou, C. M., Ji, Y., & Giger, M. L.
- Venue
- npj Breast Cancer
- Published
- 2016-05-11
- Volume
- 2
- Issue
- 1
- ISSN
- 2374-4677 (ISSN-L)
- OpenAlex
- W2549173848
- Cited by
- 364
- References
- 60
- FWCI
- 29.17
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.